Summary Four novel zinc (I1)-substituted phthalocyanines, varying in charge and hydrophobicity, were evaluated in vivo as new photosensitizers for photodynamic therapy. Two rat tumours with differing vascularity were used: a mammary carcinoma (LMC,) and a fibrosarcoma (LSBD1), with vascular components six times higher in the latter (10.8% ± 1.5) than in the former (1.8% ± 1.4). Each sensitizer was assessed for tumour response relative to normal tissue damage, and optimum doses were selected for further study, ranging from 0.5 to 20 mg kg-'. Interstitial illumination of the tumours was carried out using a 200-gm-core optical fibre with a 0.5 cm length of diffusing tip, at either 680 or 692 nm, depending on the sensitizer. Light doses of between 200 and 600 J were delivered at a rate of 100 mW from the 0.5-cm diffusing section of the fibre. Maximum mean growth delays ranged from 9 to 13.5 days depending on sensitizer and type of tumour, with the most potent photosensitizer appearing to be the cationic compound. Histopathological changes were investigated after treatment to determine the mechanism by which tumour necrosis was effected. The tumours had the appearance of an infarct and, under the conditions used, the observed damage was shown to be mainly due to ischaemic processes, although some direct tumour cell damage could not be ruled out.
Photodynamic therapy (PDT) is a method of cancer treatment that has been clinically applied to the eradication or palliation of tumours at various sites, including bladder (Benson, 1985) , brain (Kaye et al, 1987) , lung (Okunaka et al, 1991) , chest wall (Sperduto et al, 1991) , skin (Caimduff et al, 1994) and oesophagus (Moghissi et al, 1995) . The only photosensitizer so far approved for general use is Photofrin, which is a complex mixture of porphyrin monomers and oligomers. However, this drug also has relatively low light absorption in the red region of the spectrum, where light penetration in tissue is greatest, and also induces a prolonged skin photosensitivity (Richter et al, 1991) .
To overcome the problems associated with the limited depth of light penetration, chemical purity and stability, low absorption coefficient and skin photosensitivity, possible alternatives to the haematoporphyrin photosensitizers have been investigated. One such group is the phthalocyanines, which are synthetic porphyrin analogues. A number of phthalocyanine compounds have been tested in vitro (Chan et al, 1991; Boyle et al, 1993) and in vivo (Barr et al, 1991; Boyle et al, 1992) and show sufficient potential for clinical use to merit further investigation. They demonstrate strong absorbance in the red region of the spectrum and the potential for a greater PDT effect is enhanced by the increased tissue penetration by light of longer wavelength. They also appear to induce a smaller degree of skin photosensitivity than haematoporhyrin derivative (HPD) under experimental conditions (Roberts et al, 1989 ) and the compounds studied appear to be rapidly cleared from the skin.
For our studies, we have developed a series of zinc phthalocyanines. Zinc, a diamagnetic metal, extends the lifetime of the metastable triplet state (Rosenthal, 1991) and therefore enhances phototoxicity. It is also acknowledged that the polarity of the phthalocyanine affects tumour retention and cell membrane penetration (van Lier and Spikes, 1989 ). In the current work, we have used four novel zinc phthalocyanines differing in charge and hydrophobicity.
Many experimental tumours of different histologies and origins have been used when investigating the efficacy and mode of action of new photosensitizers. Each has structural differences, including the organization of their vascular morphology, depending on the tissue of origin and the site of transplantation. For these studies, two tumour models of differing vascularity were chosen to investigate the photodynamic effect of the four photosensitizers in vivo, and to identify any structure-related distinctions in tumour response.
We have therefore investigated the effect of photodynamic therapy in two transplantable rat tumour models, with four substituted zinc (II) phthalocyanines that are water soluble and demonstrate a range of ionic charges (anionic, neutral and cationic), together with strong light absorbance in the 660-700 nm range and good photosensitizing properties in vitro (unpublished).
MATERIALS AND METHODS
Tumour models Each spontaneous tumour was transplanted and used in their strain of origin. The first was a poorly differentiated fibrosarcoma (LSBD,) implanted subcutaneously, as a 2 mm fragment, in the right flank of female BDIX rats weighing between 180 and 250 kg (Gilson, 1990) . The second was a poorly differentiated mammary carcinoma (LMCI) implanted as a 2-mm pellet of minced tumour All sensitizers were dissolved in saline or phosphate-buffered saline (PBS) and then filter sterilized using a 0.22-jim filter (Gelman Sciences, Northampton, UK) before injection. (Moore, 1976) . All animals were weighed and their tumours measured daily once palpable. The mean tumour diameter was calculated from measurements of three orthogonal axes using Vernier callipers.
All animals were inbred virgins and were housed under subdued lighting operated under a 12 h dark/12 h light regimen. The animals were supplied with food and water ad libitum, and experiments were carried out within the UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia (1988) .
Photosensitizers
The zinc phthalocyanines were synthesized in the Department of Colour Chemistry, University of Leeds, UK. Preparative details and characterization data have been reported elsewhere (Griffiths et al, 1997) , and the visible absorption spectroscopic data are briefly summarized in Table 1 . The tetrasulphonate dye has a very low distribution coefficient, of about 10-4, and the other dyes are slightly less hydrophilic with values an order of magnitude lower. The sulphonamide is somewhat more hydrophilic than the carboxylic acid and the pyridinium dyes, the latter two being similar in their distribution coefficients (Table 1) . Each phthalocyanine was produced as an isomeric mixture with the substituent groups present in the 3 or 4 position in the molecule (Figure 1 ). The four compounds used were: zinc phthalocyanine tetrasulphonic acid tetra-sodium salt (ZnTSPc), this is an anionic compound with an excitation maximum (kex) and fluorescence emission maximum (Xem) at 608 and 686 nm, respectively, in Photodynamic therapy of tumours Animals were allocated for randomized treatment (n = 6 for each treatment and control group) when their tumours first reached a mean diameter of 8-10 mm (T-day). Tumours differing by 2 mm or more in any of the three measured orthogonal planes on T-day were excluded from the study. Photosensitizers were injected, at the appropriate dose (ZnTCPc and ZnTSAPc, 20 mg kg-'; ZnPPc, 0.5 mg kg-'; ZnTSPc, 10 or 5 mg kg-', depending on strain of animal), via a lateral caudal vein for females or the penile vein for males. These drug doses were determined in pilot studies (Table 2) , in which maximum growth delay was assessed together with morbidity of the underlying muscle and gut (Cruse-Sawyer, 1996) . Time delays between injection and treatment of 2, 24 and 48 h were investigated but there was no significant improvement over a time interval of 2 h, either in terms of growth delay or morbidity, at 24 h or 48 h intervals. After 2 h, a general anaesthetic was administered as an intraperitoneal injection, consisting of a 6:1 mixture of Ketalar 100 mg ml-' (Parke Davis, Gwent, UK) to Rompun 2% solution (Bayer UK, Suffolk, UK) at a dose of 0.01 ml g-'. This regimen was chosen to minimize stasis of the ileum during treatment.
The skin overlying the tumour and surrounding area was closely shaved and the animal maintained at normal body temperature.
The tumour was then swabbed using Hibiscrub and a 19G x 11/2 needle inserted through the skin and central axis of the tumour. A 200-,um-core optical fibre with a 0.5-cm cylindrical diffusing tip (Feather et al, 1989 ) was inserted and the needle removed. Interstitial illumination of the tumours was then carried out using narrow bandwidth light generated by a copper vapour laserpumped dye laser (Oxford Lasers, Abingdon, UK). The wavelengths used in this study were 692 nm (ZnTCPc and ZnTSPc) and 680 nm (ZnTSAPc and ZnPPc). The tumours received light doses calculated to be 200-600 J, delivered at a rate of 100 mW from the 0.5-cm diffusing section of the fibre. The temperature between tumour and underlying muscle was monitored during treatment in a number of animals for each light dose, using a thermocouple.
Three control sets of animals were included in each treatment group: (1) injection of 0.5 ml saline only; (2) sensitizer at the treatment dose but with no illumination; (3) tumour illumination with light alone at 600 J.
After control and PDT treatments, the animals were weighed and the tumour measured 5-6 days per week. Providing the weight of the animal did not decrease by more than 20% below its weight before treatment, the tumour was allowed to grow until it reached a mean diameter of 20 mm. At post mortem, the tumour was excised intact, leaving a small section of skin attached to indicate its orientation, and prepared for histological examination. Any signs of normal tissue response were recorded and samples taken for histology. Tumour growth delay was used to assess PDT dose response and to compare the effectiveness of the different photosensitizers used. A Student's t-test was used, applying the Bessel correction when samples were small (n < 10), to assess the significance of the data.
RESULTS

Growth response of tumours
In all control groups, light or sensitizer alone caused no deviation of the normal growth rate of either of the tumours investigated. There was no apparent dark toxicity with these compounds at 20 mg kg-'. We have also demonstrated that the rate at which the light was delivered, i.e. 100 mW using the 0.5-cm diffusing tip fibre, produces no hyperthermic effects (C Lowdell and B Dixon, personal communication). In the several animals in which the temperature between the tumour and the underlying muscle had been monitored, the maximum temperature measured was 41°C. Any alteration in the growth rate of the tumour, therefore, is considered to be a true PDT response.
The pattern of PDT response with ZnTCPc, ZnTSPc and ZnPPc was similar for both the tumour models. 7 mm mean diameter for between 5 and 7 days. After this period, tumour regrowth was detected, except with ZnPPc at 600 J, when regression of the LSBD, tumour continued until a mean tumour diameter of 5 mm was reached (Figure 2 ). There was no evidence of regrowth in two out of the three tumours treated at this light dose. With ZnTSAPc, however, the measured tumour diameter decreased only to that of the original implant at the time of treatment (8-10 mm) with no further tumour regression. Significant growth delays were achievable in both tumours after PDT with all four phthalocyanines (Figure 3) By 5-9 days there were viable tumour cells around the external margin of the encapsulated necrosis, with a dense band consisting of inflammatory infiltrate, pyknotic cells and cell debris underlying the capsule ( Figure 5D ). The central core of necrosis contained both pyknotic and karyorrhexic cells but with no histological evidence of viable tumour cells. The subcapsular band was gradually replaced by a band of karyhorrexic cells by day 12. All tumours sampled between days 12 and 15 after illumination demonstrated the same banded appearance around the perimeter of the necrotic centre ( Figure SE) . Viable tumour cells were present on one side of the capsule while on the inner edge there was a band of karyhorrexic cells, followed by a band of pyknotic cells and debris of 20 gm mean width that surrounded a central core of pyknotic and karyhorrexic cells, interspersed with collagen fibres and large spaces.
There was a highly significant difference (P < 0.01) in the mean vascularity of the two untreated tumour models, with vascular components six times higher in the LSBDI tumour (10.8% ± 1.5) than in the LMCI tumour (1.8% ± 1.4).
The central core of encapsulated necrosis was examined at higher magnifications to investigate blood vessels. Nearly all the tumour capillaries were congested with RBC and cell debris, or contained thrombi. There were also many sinusoids containing fibrous material that were not in evidence in the necrotic areas of untreated tumours.
DISCUSSION
Previous work on phthalocyanines has suggested that the more hydrophobic the derivative, the greater the uptake and photoactivity (Paquette et al, 1991 It is difficult to compare the effects of individual sensitizers only in terms of tumour growth delay. The concept of a 'photodynamic threshold dose' has been suggested, defined as the total energy that must be absorbed by the photosensitizer per unit volume of tissue to produce necrosis (Wilson et al, 1986 ). This would indicate the inherent efficiency of a particular sensitizer in a specific tissue. In this study, with ZnPPc, the lack of response in terms of tumour growth delay at 200 J may be accounted for by not achieving the threshold dose. Uptake of ZnPPc by the tumour (after injection at 10 mg kg-') has been demonstrated to be lower than that of ZnTCPc and ZnTSPc (Timmins, 1990) . If this is considered for the far lower injected dose (0.5 mg kg-' compared with 20 and 5 mg kg-' for ZnTCPc and ZnTSPc respectively), then the predicted tumour concentration of ZnPPc would be very low. This, together with the two 'cures' obtained at 600 J, suggests that, despite the relatively short growth delays observed (Table 3) , this cationic compound was the most potent of the four phthalocyanines studied. The distribution of a sensitizer throughout a tumour may also be inhomogeneous and, depending on localization, could differ between sensitizers, resulting in differing responses to PDT. Similarly, the subcellular distribution of the different sensitizers could well be important when determining their efficacy. Any evidence for there being different mechanisms, or sites, of PDT B C .S1 4.x.P -'.: t.' C11t~~f 'N 6 1'~p! i$a. !;, Srw_ I:c ' -";4I--I .' %-, i i sfT-.n "--' F.t * AC . '-&Zr"k.. action is in the differences observed in tumour response, after PDT, between ZnTSAPc and the other three compounds. With ZnTSAPC, tumours returned to, and then remained at, pretreatment size, whereas with the other compounds, there was a marked tumour regression.
The in vivo efficacy of the tetrasulphonated compound, ZnTSPc, is interesting given that the tri-and tetra-sulphonated compounds had previously been demonstrated to be less effective, both in vivo (Brasseur et al, 1988) and in vitro (Berg et al, 1989) , than the lesser substituted compounds. However, we have previously shown that a British Journal of Cancer (1998) 77(6), [965] [966] [967] [968] [969] [970] [971] [972] 970 JE Cruse-Sawyer et al A Table 3 Mean tumour growth delay (± s.e.m.) at 15 mm after PDT of LMC, and LSBD1 using the substituted zinc phthalocyanines. (n = 4-6)
Sensitizer
Mean tumour growth delay (days) 200 J 300 J 400 J 500 J 600 J LMC1 ZnTCPc 6.0 ± 1.4 7.0 ± 1.0 8.4 ± 1.9 9.6 ± 2.2 9.1 ± 1.4 ZnTSAPc 4.3 ± 1.7 4.3 ± 0.9 6.1 ± 1.3 7.2 ± 1.7 12.2 ± 0 ZnTSPc 8.1 ± 1.4 9.2 ± 1.0 12.4 ± 1.5 11.8 ± 3.0 13.6 ± 1.9
LSBD, ZnTCPc 9.1 ±1.7 8.1 +3.6 11.9±2.2 13.3±3.6 11.9±3.6 ZnTSAPc 8.5 ± 1.7 8.7 ± 2.3 8.8 ± 2.1 8.8 ± 0.7 9.3 ± 2.3 ZnPPc 0.5 ± 1.2 3.5 ± 1.5 7.9 ± 3.1 6.5 ± 2.6 -ZnTSPc 10.7 ± 1.8 12.7 ± 2.8 13 ± 1.5 13.1 ± 2.0 wavelength shift of only 12 nm has a marked effect on the tumour response after PDT with ZnTSPc (Griffiths et al, 1994) , and such a wavelength effect may account for the strong PDT response that we have observed with these substituted compounds.
The concept of a photodynamic threshold dose has also been linked with the presence or absence of a distinctive zone of tumour necrosis (Bown et al, 1986) . However, in contrast to the studies of Bown and others (van Hillegersberg et al, 1992) , no evidence of increasing necrosis with increasing light dose was obtained in this study. Neither was there any similarity in the necrosis seen after light alone compared with that seen after PDT. We measured the mean diameter of PDT-induced necrosis from 7 days after PDT onwards, in sagittal sections, and this was between 7 and 10 mm, with no correlation between the diameters and higher light doses. In treatment groups in which there was little or no PDT-induced growth delay, there were also fewer tumours showing evidence of PDT necrosis. This suggests an 'all or nothing' tumour response, which is similar to that seen in other tissues (Dereski et al, 1989) .
The necrotic centres observed in our tumours had the gross appearance of an infarct. Up to 24 h, the necrotic centre contained large quantities of red cells leaking through damaged ischaemic microcirculation. Within 48 h, the infarct had a very clearly defined border, with the centre becoming paler and firmer as a result of the possible swelling of dead cells and the subsequent squeezing of fluid out of the interstitial tissue in the infarcted area. Tumours left in situ for more than 5 days had developed the classic dull yellow of an infarct in solid tissue (Woolf, 1986) . The presence of an infarct suggests that blood vessels are the primary site of action for PDT with these phthalocyanines.
The extravasation of RBC into the perivascular stroma at 24 h was consistent with that seen using other photosensitizers (Nelson et al, 1988) . This haemorrhagia was evidence of increased vascular damage. Whether this increased permeability of the vessels is as a result of the direct destruction of the endothelial cells or of the damage to the underlying subendothelial matrix is uncertain. Others have reported complete destruction of the microvascular endothelial cells lining the capillaries at 24 h (Klaunig et al, 1985) , with severe cell damage being evident at 1 h (Winther and Ehlers, 1988) . Endothelial cell damage, however, has been suggested as occurring as a secondary response after complete disruption of the subendothelial zone, with the ultrastructure of the endothelial cell appearing normal, even though there was severe damage to the subendothelial zone (Nelson et al, 1988) and subsequent extravasation of erythrocytes.
If stromal blood flow is reduced or ceases altogether, malignant cells within the tumour may only survive for =24 h (Denekamp, 1992) . Vessels and sinusoids in the LSBDI tumour were shown to be at least partly occluded, either by RBC, thrombi or other fibrinous material. After PDT, erythrocytes are known to swell (Ben-Hur and Orenstein, 1991) . This, and the release of the vasoactive substances prostaglandin and thromboxane, which cause vasoconstriction and platelet aggregation (Fingar et al, 1992) , may result in congestion of the capillaries. Similarly, blockage of the capillaries can be effected by thrombi formation due to the release of various clotting factors from the damaged endothelial cells (Ben-Hur et al, 1988) or to the production of tumour necrosis factor by PDT-treated macrophages (Chaplin, 1991) . The fibrinous material that we observed only in the sinusoids of treated tumours may be a result of the photohaemolysis of RBCs, whereby the cells eventually lyse leaving a fibrin clot and cell debris. As the formation of a thrombus involves the 'trapping' of RBCs in a fibrin net, they are exposed to light for considerably longer than when in free circulation, thus receiving an effective PDT dose (Ben-Hur and Orenstein, 1991) . The resultant blockage of vessels by any of the above mechanisms could account for the appearance, after 48 h, of tumour cells containing pyknotic nuclei.
The appearance of the dense subcapsular band between 5 and 9 days was probably as a result of the accumulation of debris from the breakdown of cells or fragmentation of their nucleus, producing karyhorrexic cells in the necrotic centre. The displacement of this band by a layer of karyhorrexic cells would be consistent with the change over time from cells undergoing pyknosis followed by karyhorrexis.
It is not clear whether development of a subcapsular band of collagen fibres around the volume of necrosis was derived from the original capsule or in response to infarction. If the former, then the whole of the treated tumour had undergone necrosis, and subsequent regrowth was initiated by free cells in the surrounding normal tissue at the time of treatment. Initially, these cells would not be vascular dependent. This would be consistent with the nodular structure around the periphery previously described. If this collagen band was due to an infarct, then the larger peripheral vessels may have been primarily damaged by PDT and not those within the tumour. This would then explain why the gross appearance and histopathology of the necrotic area were the same for both tumour models, even though the vascularity of the two tumours was different.
From the data obtained in this study, these four novel substituted zinc phthalocyanines would appear to be efficient photosensitizers in vivo, although perhaps differing in their mode of action. While ranking is inappropriate in terms of growth delay, the most potent of these sensitizers would appear to be the cationic compound ZnPPc. The two types of tumour investigated demonstrate differing quantitative responses to PDT, and this is consistent with the findings of other workers (Chan et al, 1988) . The vasculature of a tumour is characteristic of a particular type of neoplasm (Lewis, 1927) , and the response of these tumours can be correlated with their vascularity, with the more vascular (LSBD,) demonstrating a greater response. The appearance of these tumours, both macroscopically and microscopically, indicates that the, damage sustained is due primarily to vascular injury, although there is some indication that direct tumour cell kill may also occur.
